Please Wait

Applying Filters...

Looking for Controlled & Modified Release? Find Controlled & Modified Release Agents used in Dihydroergotamine Mesylate to address drug delivery challenges on PharmaCompass.

Dihydroergotamine Mesylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 7 USDMF, 3 CEP/COS, 9 NDC API, 4 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

31 Drugs in Development

31 Drugs in Development

FINISHED DOSAGE FORMULATIONS

24 FDF Dossiers, 16 FDA Orange Book, 4 Europe, 2 Canada, 2 Listed Dossiers

RELATED EXCIPIENT COMPANIES

2 Actylis, 1 Kerry, 1 Pluviaendo

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 1 Film Formers & Plasticizers, 1 Coating Systems & Additives, 1 Topical, 1 Controlled & Modified Release

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 19 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 3 Finished Drug Prices, 4 Annual Reports

MARKET PLACE

4 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 1 US Exclusivities, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 JP, 1 Others

$ Xls

Filters

Dihydroergotamine Mesylate

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Kerry

filter Capability Reset all filters

filter Country Reset all filters

01

Kerry

SHEFFCOAT™ CG

2024 ACI Convention

Not Confirmed